Aspiriant LLC’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,204
| Closed | -$275K | – | 298 |
|
|
2024
Q4 | $275K | Sell |
1,204
-1
| -0.1% | -$229 | 0.01% | 242 |
|
|
2024
Q3 | $294K | Sell |
1,205
-70
| -5% | -$17.1K | 0.01% | 233 |
|
|
2024
Q2 | $244K | Sell |
1,275
-62
| -5% | -$11.9K | 0.01% | 255 |
|
|
2024
Q1 | $265K | Buy |
1,337
+6
| +0.5% | +$1.19K | 0.01% | 270 |
|
|
2023
Q4 | $229K | Sell |
1,331
-90
| -6% | -$15.5K | 0.01% | 273 |
|
|
2023
Q3 | $210K | Buy |
1,421
+65
| +5% | +$9.61K | 0.01% | 267 |
|
|
2023
Q2 | $296K | Hold |
1,356
| – | – | 0.02% | 225 |
|
|
2023
Q1 | $297K | Hold |
1,356
| – | – | 0.02% | 220 |
|
|
2022
Q4 | $282K | Sell |
1,356
-909
| -40% | -$189K | 0.01% | 220 |
|
|
2022
Q3 | $494K | Buy |
2,265
+1,200
| +113% | +$262K | 0.02% | 167 |
|
|
2022
Q2 | $224K | Buy |
+1,065
| New | +$224K | 0.01% | 250 |
|